Meanwhile, in ER+ BC cells, SNORA71C can increase the levels of PTGS2 and GPX4, elevated the content of GSH, suppressed the ferroptosis of ER+ BC cells, and performed a carcinogenic role. The gene discussed is GPX4; the disease is breast cancer.